| Standardization of spirometry-1994 update American Thoracic Society Am Rev Respir Dis 152, 1107-1136, 1995 | 8998* | 1995 |
| Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study NR Anthonisen, JE Connett, JP Kiley, MD Altose, WC Bailey, AS Buist, ... Jama 272 (19), 1497-1505, 1994 | 2724 | 1994 |
| A randomized trial comparing lung-volume–reduction surgery with medical therapy for severe emphysema National Emphysema Treatment Trial Research Group New England Journal of Medicine 348 (21), 2059-2073, 2003 | 2449 | 2003 |
| Cyclophosphamide versus placebo in scleroderma lung disease DP Tashkin, R Elashoff, PJ Clements, J Goldin, MD Roth, DE Furst, ... New England Journal of Medicine 354 (25), 2655-2666, 2006 | 1734 | 2006 |
| The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial NR Anthonisen, MA Skeans, RA Wise, J Manfreda, RE Kanner, ... Annals of internal medicine 142 (4), 233-239, 2005 | 1711 | 2005 |
| Long-term effects of budesonide or nedocromil in children with asthma Childhood Asthma Management Program Research Group New England Journal of Medicine 343 (15), 1054-1063, 2000 | 1271 | 2000 |
| Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease Lung Health Study Research Group New England Journal of Medicine 343 (26), 1902-1909, 2000 | 1118 | 2000 |
| American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias WD Travis, TE King, ED Bateman, DA Lynch, F Capron, D Center, ... American journal of respiratory and critical care medicine 165 (2), 277-304, 2002 | 896 | 2002 |
| Once-daily single-inhaler triple versus dual therapy in patients with COPD DA Lipson, F Barnhart, N Brealey, J Brooks, GJ Criner, NC Day, ... New England Journal of Medicine 378 (18), 1671-1680, 2018 | 852 | 2018 |
| Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial DP Tashkin, MD Roth, PJ Clements, DE Furst, D Khanna, EC Kleerup, ... The lancet Respiratory medicine 4 (9), 708-719, 2016 | 790 | 2016 |
| Patients at high risk of death after lung-volume–reduction surgery National Emphysema Treatment Trial Research Group New England Journal of Medicine 345 (15), 1075-1083, 2001 | 733 | 2001 |
| Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee LP McGarvey, M John, JA Anderson, M Zvarich, RA Wise Thorax 62 (5), 411-415, 2007 | 654 | 2007 |
| Effect of weight loss on upper airway collapsibility in obstructive sleep apnea1-3 AR Schwartz, AR Gold, N Schubert, A Stryzak Am Rev Respir Dis 144 (3 pt 1), 494-498, 1991 | 626 | 1991 |
| Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease DP Tashkin, R Elashoff, PJ Clements, MD Roth, DE Furst, RM Silver, ... American journal of respiratory and critical care medicine 176 (10), 1026-1034, 2007 | 540 | 2007 |
| C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease SFP Man, JE Connett, NR Anthonisen, RA Wise, DP Tashkin, DD Sin Thorax 61 (10), 849-853, 2006 | 537 | 2006 |
| Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea IC Gleadhill, AR Schwartz, N Schubert, RA Wise, S Permutt, PL Smith American Review of Respiratory Disease 143 (6), 1300-1303, 1991 | 535 | 1991 |
| Predictors of mortality in patients with emphysema and severe airflow obstruction FJ Martinez, G Foster, JL Curtis, G Criner, G Weinmann, A Fishman, ... American journal of respiratory and critical care medicine 173 (12), 1326-1334, 2006 | 533 | 2006 |
| Upper airway pressure-flow relationships in obstructive sleep apnea PL Smith, RA Wise, AR Gold, AR Schwartz, S Permutt Journal of applied physiology 64 (2), 789-795, 1988 | 503 | 1988 |
| An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease BR Celli, M Decramer, JA Wedzicha, KC Wilson, A Agustí, GJ Criner, ... American journal of respiratory and critical care medicine 191 (7), e4-e27, 2015 | 492 | 2015 |
| Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis B White, WC Moore, FM Wigley, HQ Xiao, RA Wise Annals of internal medicine 132 (12), 947-954, 2000 | 491 | 2000 |
William Checkley, MD, PhDAssociate Professor of Medicine, International Health and Biostatistics, Pulmonary and Critical CareBekræftet mail på jhmi.edu
